HEPION PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
HEPION PHARMACEUTICALS, INC. (HEPA) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $247.44 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-13
- HEPION PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $7.19K.
- HEPION PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $240.25K, a 44.85% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $112.22K.
- HEPION PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$88.09K.
- HEPION PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $1.43K.
- HEPION PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$4.55M, a 1600.59% decline from fiscal 2023.
- HEPION PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $302.92K, a 86.51% decline from fiscal 2022.
- HEPION PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $2.25M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 5 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 8 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $247.44K 10-Q · filed 2026-08-13 | $359.66K derived: sum of 3 quarters · filed 2026-08-13 | $271.57K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $240.25K 10-Q · filed 2026-05-14 | $352.47K derived: sum of 2 quarters · filed 2026-05-14 | $264.38K derived: sum of 3 quarters · filed 2026-05-14 | $75.83K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $112.22K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $24.12K derived: sum of 2 quarters · filed 2026-03-12 | -$164.43K derived: sum of 3 quarters · filed 2026-08-13 | $1.43K 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$88.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$276.65K derived: sum of 2 quarters · filed 2026-08-13 | -$110.79K 10-Q · filed 2025-11-12 | -$359.16K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$188.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$22.69K 10-Q · filed 2026-08-13 | -$271.07K derived: sum of 3 quarters · filed 2026-08-13 | -$600.35K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $165.86K 10-Q · filed 2026-05-14 | -$82.51K derived: sum of 2 quarters · filed 2026-05-14 | -$411.80K derived: sum of 3 quarters · filed 2026-05-14 | -$1.88M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$248.37K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$577.66K derived: sum of 2 quarters · filed 2026-03-12 | -$2.05M derived: sum of 3 quarters · filed 2026-03-12 | -$4.55M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$329.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.80M derived: sum of 2 quarters · filed 2025-11-12 | -$4.30M 10-Q · filed 2025-11-12 | -$5.43M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$3.97M 10-Q · filed 2025-08-14 | -$5.10M derived: sum of 3 quarters · filed 2025-08-14 | -$6.48M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$2.50M 10-Q · filed 2025-05-19 | -$3.63M derived: sum of 2 quarters · filed 2025-05-19 | -$5.01M derived: sum of 3 quarters · filed 2025-05-19 | -$2.76M derived: sum of 4 quarters · filed 2025-05-19 | ||||
| 2023-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-08 | -$2.51M derived: sum of 2 quarters · filed 2025-04-08 | -$263.70K derived: sum of 3 quarters · filed 2025-04-08 | $302.92K 10-K · filed 2025-04-08 | ||||
| 2023-09-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $864.37K derived: sum of 2 quarters · filed 2024-11-14 | $1.43M 10-Q · filed 2024-11-14 | $1.83M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $2.82M 10-Q · filed 2024-08-13 | $3.21M derived: sum of 3 quarters · filed 2024-08-13 | -$2.67M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $566.62K 10-Q · filed 2024-05-21 | $962.58K derived: sum of 2 quarters · filed 2024-05-21 | -$4.92M derived: sum of 3 quarters · filed 2024-05-21 | $2.74M derived: sum of 4 quarters · filed 2024-05-21 | ||||
| 2022-12-31 | $395.95K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$5.49M derived: sum of 2 quarters · filed 2024-04-16 | $2.17M derived: sum of 3 quarters · filed 2024-04-16 | $2.25M 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | -$5.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $1.77M derived: sum of 2 quarters · filed 2023-11-20 | $1.85M 10-Q · filed 2023-11-20 | $2.02M derived: sum of 4 quarters · filed 2023-11-20 | ||||
| 2022-06-30 | $7.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $7.74M 10-Q · filed 2023-08-14 | $7.91M derived: sum of 3 quarters · filed 2023-08-14 | $6.88M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $76.30K 10-Q · filed 2023-05-12 | $249.02K derived: sum of 2 quarters · filed 2023-05-12 | -$783.10K derived: sum of 3 quarters · filed 2023-05-12 | $910.73K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $172.72K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-10 | -$859.41K derived: sum of 2 quarters · filed 2023-04-10 | $834.43K derived: sum of 3 quarters · filed 2023-04-10 | -$1.07M 10-K · filed 2023-04-10 | ||||
| 2021-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $661.71K derived: sum of 2 quarters · filed 2022-11-14 | -$1.24M 10-Q · filed 2022-11-14 | -$539.24K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$208.44K 10-Q · filed 2022-08-15 | $492.88K derived: sum of 3 quarters · filed 2022-08-15 | $1.88M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$1.90M 10-Q · filed 2022-05-16 | -$1.20M derived: sum of 2 quarters · filed 2022-05-16 | $184.11K derived: sum of 3 quarters · filed 2022-05-16 | $859.25K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $701.32K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $2.09M derived: sum of 2 quarters · filed 2022-04-08 | $2.76M derived: sum of 3 quarters · filed 2022-04-08 | $3.04M 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $2.06M derived: sum of 2 quarters · filed 2021-11-15 | $2.34M 10-Q · filed 2021-11-15 | $2.45M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $675.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $952.85K 10-Q · filed 2021-08-16 | $1.06M derived: sum of 3 quarters · filed 2021-08-16 | $1.23M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $277.71K 10-Q · filed 2021-05-14 | $386.66K derived: sum of 2 quarters · filed 2021-05-14 | $552.77K derived: sum of 3 quarters · filed 2021-05-14 | $6.86K derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $108.95K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $275.06K derived: sum of 2 quarters · filed 2021-03-31 | -$270.86K derived: sum of 3 quarters · filed 2021-03-31 | -$317.05K 10-K · filed 2021-03-31 | -$424.36K 10-K · filed 2020-05-14 | |||
| 2019-09-30 | $166.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$379.80K derived: sum of 2 quarters · filed 2020-11-16 | -$425.99K 10-Q · filed 2020-11-16 | $425.99K 10-Q · filed 2019-11-14 | -$1.03M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | -$545.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$592.10K 10-Q · filed 2020-08-12 | -$1.20M derived: sum of 3 quarters · filed 2020-08-12 | -$2.15M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | -$46.19K 10-Q · filed 2020-06-29 | -$650.81K derived: sum of 2 quarters · filed 2020-06-29 | -$1.60M derived: sum of 3 quarters · filed 2020-06-29 | -$1.09M derived: sum of 4 quarters · filed 2020-06-29 | ||||
| 2018-12-31 | -$604.62K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-14 | -$1.55M derived: sum of 2 quarters · filed 2020-05-14 | -$1.04M derived: sum of 3 quarters · filed 2020-05-14 | -$897.70K 10-K · filed 2020-05-14 | ||||
| 2018-09-30 | -$948.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$439.09K derived: sum of 2 quarters · filed 2019-11-14 | -$293.07K 10-Q · filed 2019-11-14 | $293.07K 10-Q · filed 2018-11-14 | -$419.00K derived: sum of 4 quarters · filed 2019-11-14 | |||
| 2018-06-30 | $509.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $655.65K 10-Q · filed 2019-08-14 | $529.72K derived: sum of 3 quarters · filed 2019-08-14 | $544.45K derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $146.01K 10-Q · filed 2019-05-15 | $20.09K derived: sum of 2 quarters · filed 2019-05-15 | $34.81K derived: sum of 3 quarters · filed 2019-05-15 | $506.05K derived: sum of 4 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | -$125.93K derived: 10-K 6 month − 10-Q 3 month · filed 2019-03-14 | -$111.21K 10-K · filed 2019-03-14 | $360.04K derived: sum of 3 quarters · filed 2019-03-14 | -$390.48K derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-09-30 | $14.72K 10-Q · filed 2017-11-14 | $485.97K derived: sum of 2 quarters · filed 2018-08-14 | -$264.56K 10-Q · filed 2018-11-14 | -$2.20M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-06-30 | $471.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$279.28K 10-Q · filed 2018-08-14 | -$2.22M derived: sum of 3 quarters · filed 2018-08-14 | -$2.13M 10-K · filed 2019-03-14 | ||||
| 2017-03-31 | -$750.52K 10-Q · filed 2018-05-15 | -$2.69M derived: sum of 2 quarters · filed 2018-05-15 | -$2.60M 10-Q · filed 2017-04-12 | -$1.82M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | -$1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | -$1.85M 10-Q · filed 2017-02-14 | -$1.06M derived: sum of 3 quarters · filed 2018-03-26 | -$536.81K derived: sum of 4 quarters · filed 2018-03-26 | ||||
| 2016-09-30 | $88.92K 10-Q · filed 2017-11-14 | $873.38K derived: sum of 2 quarters · filed 2018-03-26 | $1.40M derived: sum of 3 quarters · filed 2018-03-26 | $947.02K derived: sum of 4 quarters · filed 2018-03-26 | ||||
| 2016-06-30 | $784.46K derived: 10-KT 12 month − 10-Q 9 month · filed 2018-03-26 | $1.31M derived: sum of 2 quarters · filed 2018-03-26 | $858.10K derived: sum of 3 quarters · filed 2018-03-26 | $3.14M 10-KT · filed 2018-03-26 | ||||
| 2016-03-31 | $527.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-12 | $73.64K derived: sum of 2 quarters · filed 2017-04-12 | $2.35M 10-Q · filed 2017-04-12 | $2.67M derived: sum of 4 quarters · filed 2017-04-12 | ||||
| 2015-12-31 | -$454.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | $1.82M 10-Q · filed 2017-02-14 | $2.15M derived: sum of 3 quarters · filed 2017-02-14 | $3.28M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-09-30 | $2.28M 10-Q · filed 2016-11-14 | $2.60M derived: sum of 2 quarters · filed 2016-11-14 | $3.74M derived: sum of 3 quarters · filed 2016-11-14 | $3.82M derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | $322.42K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $1.46M derived: sum of 2 quarters · filed 2016-09-28 | $1.54M derived: sum of 3 quarters · filed 2016-09-28 | $1.52M 10-K · filed 2016-09-28 | ||||
| 2015-03-31 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-13 | $1.22M derived: sum of 2 quarters · filed 2016-05-13 | $1.19M 10-Q · filed 2016-05-13 | |||||
| 2014-12-31 | $83.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-12 | $57.54K 10-Q · filed 2016-02-12 | ||||||
| 2014-09-30 | -$25.84K 10-Q · filed 2015-11-12 | |||||||
| 2013-12-31 | -$52.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | $16.92K 10-Q · filed 2014-02-05 | $143.81K 10-Q · filed 2014-02-05 | |||||
| 2013-09-30 | $69.64K 10-Q · filed 2013-11-19 | $196.52K 10-Q · filed 2013-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |